Equibles does not estimate personal net worth.
Earlier roles on record: CFO at CareDx, Inc. (CDNA) until December 31, 2020. The proxy statement of CareDx, Inc. reports total compensation of $3,443,952 for Michael Bell in fiscal 2020, including a base salary of $383,249. Disclosed compensation is on record for 4 fiscal years. Michael Bell has spoken on 3 earnings calls across 1 company, most recently for CareDx, Inc. on October 7, 2020. The companies whose calls Michael Bell spoke on are classified in the Healthcare sector.
“Turning first to the income statement, total revenue for the third quarter was fifty-three point four million, a year-over-year growth of fifty-eight percent. Our top line growth was driven by accelerated penetration this quarter.”
“Turning first to the income statement, total revenue for the second quarter was $41.8 million, reflecting a 33% increase from the previous year. This revenue growth was mainly driven by AlloSure Kidney and AlloMap Heart.”
“Turning first to the income statement, total revenue for the first quarter was $38.4 million, a year-over-year growth of 48%. The growth in revenue was primarily driven by AlloSure Kidney and AlloMap Heart as well as continued adoption and center penetration of AlloSure Kidney.”
Start not stated–2020-12-31
CDNA
Diagnostics & Research · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | CareDx, Inc. (CDNA) | Former Chief Financial Officer | $383,249 | $3,443,952 |
| 2019 | CareDx, Inc. (CDNA) | Former Chief Financial Officer | $355,383 | $2,685,687 |
| 2018 | CareDx, Inc. (CDNA) | Former Chief Financial Officer | $340,653 | $2,095,009 |
| 2017 | CareDx, Inc. (CDNA) | Chief Financial Officer | $237,292 | $690,760 |
